David Marek

2019 - Axsome Therapeutics

In 2019, David Marek earned a total compensation of $3M as Chief Commercial Officer at Axsome Therapeutics.

Compensation breakdown

Bonus$65,000
Non-Equity Incentive Plan$231,000
Option Awards$2,545,597
Salary$128,333
Total$2,969,931

Marek received $2.5M in option awards, accounting for 86% of the total pay in 2019.

Marek also received $65K in bonus, $231K in non-equity incentive plan and $128.3K in salary.

Rankings

In 2019, David Marek's compensation ranked 4,130th out of 13,971 executives tracked by ExecPay. In other words, Marek earned more than 70.4% of executives.

ClassificationRankingPercentile
All
4,130
out of 13,971
70th
Division
Manufacturing
1,500
out of 5,695
74th
Major group
Chemicals And Allied Products
526
out of 2,194
76th
Industry group
Drugs
444
out of 1,880
76th
Industry
Pharmaceutical Preparations
340
out of 1,392
76th

Pay ratio

David Marek's Pay$2,969,931
Median Employee's Pay$166,021
Pay Ratio

18

to 1

In 2019, the annual total compensation of David Marek was $2,969,931.

The annual total compensation of the median employee at Axsome Therapeutics was $166,021.

The ratio of David Marek's pay to the pay of median employee was therefore 18 to one.

Source: SEC filing on April 21, 2020.

Marek's colleagues

We found three more compensation records of executives who worked with David Marek at Axsome Therapeutics in 2019.

2019

Herriot Tabuteau

Axsome Therapeutics

Chief Executive Officer

2019

Mark MA

Axsome Therapeutics

Chief Operating Officer

2019

Nick Pizzie

Axsome Therapeutics

Chief Financial Officer

News

In-depth

You may also like